BCM Global Programs to serve as clinical core for NIH POCTRN - POCTRN
The Point-of-Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.
2023 POCTRN awardees announced
Congratulations to the six Technology Research and Development Centers around the country that comprise the Point-of-Care Technology Research Network (POCTRN). Established in 2007 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), POCTRN has facilitated a pipeline of technologies and expertise that address health conditions from heart disease to cancer to HIV/AIDS and that extends across domains from child health to global health.Coordination among all the centers will continue to be led by CIMIT, who will reprise their role as the POCTRN Coordinating Center. Each center will use a milestone-driven approach to focus resources on the development of technologies that demonstrate the highest chance of success. Learn more about each center below.
Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern
Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University
null BCM Global Programs to serve as clinical core for NIH POCTRN
BCM Global Programs to serve as clinical core for NIH Point of Care Technologies Research Network
Baylor College of Medicine Global Programs and the Dan L Duncan Comprehensive Cancer Center will serve as the clinical core for the Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC), one of the National Institute of Health’s newest Point of Care Technologies Research Network (POCTRN) centers. The network focuses on the development and translation of point-of-care cancer screening and early detection technologies for global health.
POCTRN and COVID-19
In response to COVID-19 pandemic, POCTRN has helped to launch the Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. We have also curated a number resources and additional funding opportunities on our resources page.
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
Fogarty International Center
Office of Behavioral and Social Sciences Research
Office of AIDS Research
Office of Disease Prevention